In conclusion, there is accumulating evidence of Gas6/TAM pleiotropic physiological roles, thus fostering future research studies focusing on identifying safe and effective clinical interventions targeting this signaling pathway to manage different disease conditions such as chronic fibrosis or the current COVID-19 outbreak. This evidence concerns the gene GAS6 and COVID-19.